Nycomed and Micromet to Collaborate on Antibody Development
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 85 (Table of Contents)
Published: 7 Jul-2007
DOI: 10.3833/pdr.v2007.i85.313 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Nycomed and Micromet entered into research collaboration agreement to develop Micromet’s anti-GM-CSF antibodies, including MT203 for treating inflammatory and autoimmune diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS